Clinical Trial Update: Adjuvant Gemcitabine and Capecitabine Chemotherapy in Resected Pancreatic Cancer Following Neoadjuvant Chemotherapy [Phase 2]

View source ↗

Summary

Phase 2 trial of adjuvant gemcitabine and capecitabine chemotherapy after neoadjuvant therapy in resected pancreatic cancer is updating its status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Capecitabine (capecitabine)
• Gemcitabine (Gemcitabine)

Snippet

Sponsor: Rutgers, The State University of New Jersey | Conditions: Pancreatic Cancer | Phase 2 | Status: UNKNOWN